3DPrint.com May 15, 2024
Vanesa Listek

Building on its proven track record in groundbreaking projects like glaucoma stents and microneedles, Boston Micro Fabrication (BMF) launched a new subsidiary, BMF Biotechnology Inc. Headquartered in San Diego, California, the division uses the brand’s 3D printing technology to create and commercialize microfluidic chips that accurately mimic human body functions. These organ-on-a-chip platforms or BioChips will allow faster, more precise testing and research for pharmaceutical and cosmetic industries, opening up new possibilities for medical progress and better patient care.

What Are BioChips?

Equipped with an integrated network of tiny channels that function similarly to blood vessels in the human body, these chips allow the flow of fluids, mimicking how nutrients and wastes are exchanged in human tissues. This is key...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Technology
AMS 2025: Enabling & Scaling 3D Printing in Healthcare, Part 2
3D-printed implant supports heart valve repair
Beyond DeepSeek: Reimagining AI Integration in China’s 3D Printing Industry
Advanced 3D Printed Medtech Solutions Transform Healthcare Treatments and Improve Patient Outcomes
The Importance of Services in 3D Printing: Steady Growth and Promising Potential

Share This Article